Publications by authors named "J Strouboulis"

Transcription factor TFII-I/GTF2I is ubiquitously expressed and has been shown to play a role in the differentiation of hematopoietic cells and in the response to various cellular stressors. We previously demonstrated that TFII-I acts as a repressor of adult β-globin gene transcription and positively regulates expression of stress response proteins, including ATF3. Here we analyzed the function of TFII-I in TF-1 cells during erythroid differentiation and in response to cellular stress, including unfolded protein response, hypoxia, and oxidative stress.

View Article and Find Full Text PDF

Ineffective erythropoiesis (IE) is defined as the abnormal differentiation and excessive destruction of erythroblasts in the marrow, accompanied by an expanded progenitor compartment and relative reduction in the production of reticulocytes. It is a defining feature of many types of anemia, including beta-thalassemia. GATA1 is an essential transcription factor for erythroid differentiation, known to be implicated in hematological conditions presenting with IE, including beta-thalassemia and congenital dyserythropoietic anemia.

View Article and Find Full Text PDF
Article Synopsis
  • Recent advancements in gene editing, particularly methods like CRISPR-Cas9, present promising therapeutic strategies for Sickle Cell Disease (SCD), which is caused by a mutation in the β-globin gene and currently lacks comprehensive treatment options.
  • While there are existing medications for symptom relief, allogeneic hematopoietic stem cell transplantation remains the only curative option, highlighting the urgent need for innovative therapies.
  • This review examines how gene editing techniques can correct genetic mutations or boost fetal hemoglobin production, and discusses ongoing clinical trials that aim to translate these advancements into effective treatments for SCD.
View Article and Find Full Text PDF

The clinical severity of sickle cell disease (SCD) is strongly influenced by the level of fetal haemoglobin (HbF) persistent in each patient. Three major HbF loci (BCL11A, HBS1L-MYB, and Xmn1-HBG2) have been reported, but a considerable hidden heritability remains. We conducted a genome-wide association study for HbF levels in 1006 Nigerian patients with SCD (HbSS/HbSβ0), followed by a replication and meta-analysis exercise in four independent SCD cohorts (3,582 patients).

View Article and Find Full Text PDF